Form 4: Ironwood Pharmaceuticals CEO Thomas McCourt Reports Stock Award
SEC Form 4 Filing
CEO Thomas McCourt of Ironwood Pharmaceuticals reports the acquisition of performance-based restricted stock units.
Summary
- On March 5, 2024, Thomas A. McCourt, CEO of Ironwood Pharmaceuticals, reported a transaction involving the company's Class A Common Stock.
- McCourt acquired 132,438 performance-based restricted stock units (PSUs).
- These PSUs represent a contingent right to receive shares of Ironwood's Class A Common Stock upon vesting, which is tied to the achievement of a specified price per share.
- McCourt also reported owning 1,097,650 shares of Class A Common Stock directly after the reported transaction.
- Additionally, McCourt was granted a restricted stock unit award, vesting in three annual installments of 33.33% starting approximately one year from the grant date.
Sentiment
Score: 7
Explanation: The document reflects standard executive compensation practices, aligning management interests with shareholder value. The sentiment is neutral to positive as it indicates confidence in future performance.
Positives
- The acquisition of performance-based restricted stock units aligns the CEO's interests with the company's performance and shareholder value.
- The vesting of PSUs is tied to the achievement of a specified price per share, incentivizing the CEO to drive stock price appreciation.
Future Outlook
The document does not contain explicit forward-looking statements, but the vesting of the PSUs is tied to future stock price performance.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, which is important for investor confidence.
Comparison to Industry Standards
- Stock-based compensation is a common practice in the pharmaceutical industry to align executive compensation with company performance.
- Vesting schedules and performance-based metrics are often used to incentivize long-term value creation.
- Similar to other pharmaceutical companies, Ironwood uses restricted stock units and performance-based units as part of its executive compensation packages.
Stakeholder Impact
- Shareholders: Provides transparency into executive compensation and alignment of interests.
- Employees: May impact morale and perception of fairness in compensation practices.
Key Dates
| Date | Description |
|---|---|
| 03/05/2024 | Date of transaction: Acquisition of performance-based restricted stock units and restricted stock unit award. |
| 02/28/2027 | Expiration date of the performance-based restricted stock units. |
| 03/07/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.